Podcasts about Washington School

This week I'm talking with Dr. Maggie Sibley, a clinical psychologist and professor at the University of Washington School of Medicine. Dr. Sibley has spent over two decades studying ADHD, and is author or co-author of over 120 research papers on the topic. And she is the author of Parent-Teen Therapy for Executive Function Deficits and ADHD: Building Skills and Motivation. So recently, when I was working on the newsletter for the show, I came across an article about ADHD titled "Study describes fluctuations, remissions seen with ADHD,” and that felt like it was worth investigating more. While reading through the paper that was linked into the article I got to thinking, “hey, I'd love to ask some more questions about the findings in this paper,” and it occurred to me, hey, I can just reach out to the author of the paper for a conversation on the podcast. And so that's what today's show is all about, we dig into that paper, titled “Characteristics and Predictors of Fluctuating Attention-Deficit/Hyperactivity Disorder in the Multimodal Treatment of ADHD (MTA) Study” that looks into symptom fluctuation based on the a review of the Multimodal Treatment of ADHD (MTA) Study. We talk about how ADHD symptoms don't just disappear but actually tend to fluctuate — a lot more than many researchers expected. We also dive into why having more going on in life might actually make your ADHD symptoms less severe (or how that's just one interpretation of the results), how motivation works for us, and what it means to find your own “sweet spot” of structure. Plus, we get into the upcoming diagnostic guidelines for adult ADHD from the American Professional Society for ADHD and Related Disorders. This is definitely an episode you don't want to miss if you really enjoy the sciency side of things. Start Freedom today! Use code ADHD40 to get them 40% off a Freedom Yearly premium subscription! Listen to the Climbing the Walls podcast here! If you'd life to follow along on the show notes page you can find that at HackingYourADHD.com/222 YouTube Channel My Patreon This Episode's Top Tips ADHD symptoms don't always follow a straight decline or improvement. Symptoms can often fluctuate, sometimes improving for years and then intensifying again. Expect waves, not a straight line, and don't blame yourself when experiencing higher-than-normal symptoms. When you're in a phase where ADHD feels more manageable, that's a great time to try and take on more meaningful responsibilities — like work, school, or parenting — that can help create external structure and reinforce good patterns. While having more life demands (like a busy schedule, work responsibilities, or kids) can improve ADHD functioning by creating natural urgency and external motivators, it's also important to make sure it doesn't tip into overload. Not all clinicians are trained to recognize ADHD in adults, especially when childhood histories are murky. If your concerns are dismissed, it's okay — and important — to seek out a more knowledgeable provider. And on that note, look out for updated diagnostic and treatment guidelines for adult ADHD from APSARD (American Professional Society for ADHD and Related Disorders). While these guidelines won't change any of the diagnostic criteria in the DSM, they will help give clinicians clearer, evidence-based advice on how to apply them when evaluating ADHD in adults. 

Nurse Josephine Ensign was homeless herself before she became a leading voice in the national conversation on homelessness. She writes about the visceral experience of being homeless, while examining which policies work — and which don't. She has written several books on the subject, including “Way Home: Journeys Through Homelessness.” It's a plea to keep all members of society in focus and in the conversation. Ensign is in Rochester as a guest of SUNY Brockport, and this hour, she joins us on “Connections.” In studio:Josephine Ensign, DrPH, ARNP, professor of nursing at the University of Washington School of Nursing and author of multiple books, including "Way Home: Journeys Through Homelessness"

On this week's Labor Radio Podcast Weekly: Hands off our public services, our public workers, and our public spaces.

The amount of time children and adolescents spend with a screen is absolutely stunning. Lots of people, including parents, health leaders, educators, elected leaders from both parties I might mention, and even children themselves, are highly concerned and are discussing what might be done about all this. I'm delighted to begin this series of podcasts on children and screen time. Today we're welcoming two very special guests who can talk about this topic in general, and especially about what's being done to protect children and adolescents. Several podcasts will follow this one that deal with food and nutrition in particular. Our first guest, Kris Perry, is Executive Director of Children and Screens, an organization devoted to protecting children. In the digital world by addressing media's impact on child development, communicating state-of-the-art information, and working with policymakers. Prior to joining children in Screens, Kris was senior advisor of the Governor of California and Deputy Secretary of the California Health and Human Services Agency. Our other guest, Dr. Dimitri Christakis is a professor of pediatrics at the University of Washington School of Medicine, and director of the Center for Child Health Behavior and Development at Seattle Children's. He's also editor-in-chief of JAMA Pediatrics and both Chief Scientific Officer and Chair of the Scientific Advisory Board of Children and Screens. He's also the co-editor of a new book that I'm very excited to discuss. Interview Summary Download The Handbook of Children and Screens: https://link.springer.com/book/10.1007/978-3-031-69362-5 Kris, let's start with you. Could you set the stage and give us some sense of how much time children spend in front of screens, children and adolescents, and what devices are being used and what kind of trends are you seeing? Yes, I'd be happy to. I had better news for your listeners, but as you might imagine, since the advent of the smartphone and social media, the youth digital media use has been increasing each year. Especially as children get older and have increasing demands on their time to use screens. But let's just start at the beginning of the lifespan and talk about kids under the age of two who shockingly are spending as much as two hours a day on screens. Most spend about 50 minutes, but there's a significant chunk spending up to two hours. And that rises to three or three to five hours in childhood. And eventually in adolescence, approximately eight and a half hours a day our adolescents are spending online. Also wanted to talk a little bit about middle childhood children, six to 12 years of age. 70% of them already have a social media account, and we all know social media wasn't designed for children. And there are restrictions on children under 13 using them, and yet children six to 12 most have an account already. Over half of four-year-olds have a tablet and two thirds of children have their own device by the age of eight; and 90% of teens. This probably won't be surprising, and yet we should really think about what this means; that 90% of teens are using YouTube, 60% are on TikTok and Instagram, and 55% use Snapchat. I'll stop by ending on a really alarming statistic. Oh my, there's more? There's more. I know it! I told you. I'll be the bearer of bad news so that we can talk about solutions later. But, children are checking their devices as often as 300 times per day. 300 times. 300 times per day, and we're talking about screen time right now. And we know that when you're using time to be on screens, you are not doing something else. And we know that childhood is full of challenges and skill building and mastery that requires repetition and tenacity and grit and effort. And the more children are on their screens, whether it's social media or other entertainment, they're not doing one of these other critical child development tasks. That's pretty amazing. And the fact that the older kids are spending more time on before a screen than they are in school is pretty alarming. And the younger, the really youngest kids, that's especially alarming. So, Dimitri, why should we fret about this? And I realize that fret is kind of a mild word here. Maybe all I'll panic would be better. But what are some of the major concerns? Well, I don't think panic is ever the right reaction, but the numbers Kris conveyed, you know, I think do paint a, let's say, concerning story. You know, the simple reality is that there's only so much time in a day. And if you think about it, teenagers in particular should sleep for eight to 10 hours a day at a minimum. They really should be in school six and a half, seven hours a day. And then when you add the numbers, Kris conveyed, you realize that something's giving because there isn't enough time left to spend eight and a half hours a day. The two things at a minimum that are giving are sleep. Kids are losing sleep to be on screens. And I'm sorry to say that they're losing school while they're on screens. We just published a paper that used passive sensing to see where and when children are on their screens. And found that the typical child in the United States spends an hour and a half during the school day on their device. And it's not, before any of your guests ask, on Wikipedia or Encyclopedia Britannica. It's on the usual suspects of social media, TikTok, etc. So, you know, we talk about displacement, and I think it's pretty obvious what's being displaced during school hours. Its time focused on learning if it's in the classroom, and time focused on being authentically present in real time and space if it's during recess. School hours are precious in that way, and I think it is concerning that they're spending that much time in school. And I told you the median. Of course, some kids are above that, a significant half of them are above it. And at the high end, they're spending 30 to 40% of school time on screens. Now, some schools have enacted policies. They don't typically enforce them very well. One of the things that drives me nuts, Kelly, is that as an academic, you know we love to argue amongst ourselves and hem and haw. And this issue about whether or not there's such a phenomenon as digital addiction is still being hotly debated. Honestly, the only behavioral addiction that's being seriously considered at this point is gaming disorder. The DSM-5 didn't consider gaming, considered it, but didn't include, it said it needed further study in 2013. In 2022, the WHO did include gaming disorder as an ICD-11 diagnosis. But just as further evidence how slow science is compared to technology., I mean gaming, while it's still an entity, represents a small fraction of most people's screen time. And the numbers that Kris conveyed, a small fraction of that for some on average was gaming. For some people, it's their screen use of choice, but for many, it's social media. YouTube, although I consider YouTube to be a social media, etc. And at the high end when you hear the numbers Kris conveyed in my mind that's a behavioral addiction any way you define it. Well, and if you think about things that we all agree are addictive, like nicotine and alcohol and heroin, people aren't doing it 300 times a day. So it's really pretty remarkable. And that's exactly right. One of the salient criteria for those addictions is that it's interfering with activities of daily living. Well, you can't be on a screen for nine hours a day when you're supposed to be asleep for 10 and at school for six without interfering with activities of day. The math isn't there. And things like being physically active and going out and playing. That's right. It doesn't add up. So, you don't need the DSM-5. You don't need a psychiatrist. You need a mathematician to tell you that there's too much time on this thing. Alright, so Kris, talk to us if you will, about the Children and Screens organization. I have a lot of respect for the organization and its work. Tell us how it got started and what its objectives are. Well, it's so great to be on this show with you and get to see you in your day job, Kelly. Because you've been an advisor, like Dimitri, to the institute almost since its inception, which is in 2013. As you know, our founder, Dr. Pamela Hurst-Della Pietra, really became concerned as a parent about the way digital media was impacting her children and sought out some answers. Well, what does this mean? Why is this happening? What should I do? And found out that this, of course, is 2013, this is a long time ago. There wasn't that much research yet. And it was multidisciplinary. In other words, there might be a study among neuroscientists or developmental psychologists, even ophthalmologists. But there really hadn't been, yet, a concerted effort to bring these different disciplines and the research together to try to answer some of these hard questions about the impact on kids. And lo and behold, here we are, almost 13 years since the advent of the smartphone and social media. And there is an astounding amount of research across disciplines. So, what we do at the institute is we try to translate it as fast as we can and make it actionable for parents, providers, and policy makers. And we do that through our Ask the Experts webinar series where we bring the experts themselves directly to our audience to talk about these impacts and answer questions. We also create printables, you might say, like tip sheets and Research at a Glance Digest, and newsletters and FAQs and we've upgraded our website to make it very navigable for parents of kids of all ages. I even started my own podcast this year, which has been really fun. Dimitri was my first guest, so it's great to see him here. And we have convenings. We're having our third Digital Media Developing Mind Scientific Congress this summer where the experts come together in person to discuss issues. And we really try to focus them on advancing research and supporting it, translating it, and positioning the issue as a policy priority. We'll be in Washington, DC where we know lawmakers are grappling with the impact of digital media on child development, how to make online, products safer for kids and protect their data. The Institute is in the middle of all of this, trying to facilitate more discussion, more results and more support for parents primarily. Kris, a couple of things occur to me. One is that the breadth of work you do is really very impressive because you're not only having very hands-on kind of in the real world ex advice for parents on how to navigate this world, but you have advice for and helpful resources for policy makers and for researchers and people. It's really quite an impressive breadth of work. The other thing that occurred to me is that I don't think you and I would have any podcast career at all if it hadn't been for Dimitri helping us out. So thanks Dimitri. Yeah. So, let me ask you, Dimitri, so I know that both you and Kris are committed to an evidence-based approach to making policy. Yeah. But technology advances way more quickly than scientists can evaluate it. Much less come up with policies to deal with it. And by the time research gets funded, completed, published, you're on to eight new levels of technology. So how does one handle this fundamental problem of pace? It's a really good question. I mean, I can tell you that we should at a minimum learn from the mistakes we've made in the past. And, you know, one of the most critical, frankly, that most people don't really understand is that we talk about the age at which children get social media accounts in this country. Kris pointed out that actually pre-teens routinely have social media accounts. Social media companies do very little to age gate. They're trying to do more now, but even the age at which we've accepted it is being normative is 13. Few people know where that comes from. That doesn't come from talking to pediatricians, psychologists, parents about what age is the appropriate age. It comes entirely from COPPA (Children's Online Privacy Protection Act), which basically was the original privacy act that said that before the age of 13, companies could not collect data from children. So, because these companies were interested in collecting data, they set the age at 13 so as to not have any constraints on the data they collected. Well, that's not even common sense-based policy, let alone evidence-based policy. And it's never been revisited since. It's very troubling to me. And as things move forward, I think we have to learn from those mistakes. Medicine has a maxim which is do no harm. We use that phrase a lot and I think it's a good one in this case. I think it's a particularly good one as we see the new technologies emerging around artificial intelligence. And you know, again, like any new technology, it has incredible upside. We made the mistake and we're still paying for it, about not appreciating the downsides of social network sites, and frankly, the internet in general. And I would hope we put guardrails in place now. And if you will apply the same standard we apply to other non-technology based products. You can't introduce a new pharmaceutical to anybody, let alone to children, until you show it's safe and effective. You can't bring toys to the world that are dangerous. Why do we have more safety precautions around toys than we do around websites for children? You know, a lot of it involves changing defaults, doesn't it? Because if the default is that government or somebody out there has to prove that something is harmful before it gets taken away. That changes everything then if you began at a different point where these companies have to prove that these things are safe. Correct. Or they're permitted. Then the companies would find workarounds and they would play games with that too, but at least that would help some. Well, it would help some. And at least we'd be philosophically in the right place. By the way, Kris didn't say it, so I'll say it. You know, the mission of Children and Screens, lest we sound like Luddites here, is not get kids away from technology. Take away their smartphones. We all recognize that technology is here to stay. I think all of us appreciate the incredible upside that it brings to children's lives. The mission of Children and Screens is to help children lead healthy lives in a digital world. And part of the reason she and I often talk about the concerns we have is because the pros make the case for themselves. I mean, you know, no one needs to come here and tell you how amazing it is that you could Google something or that you could get somewhere with GPS. I mean, we know it's amazing and we all rely on it. And none of us are ever talking about getting rid of that stuff. That makes good sense. It's like, you know, children benefit from the fact that they can get around with their parents in the automobile. But you want to have car seats in there to protect them. Exactly. And that's exactly right. There needs to be assurances of safety and they're none. I mean, they're really virtually none. The age getting is a joke. And even if we accept it as effective, the age set of 13 is too young, in my opinion. We started this conversation talking about these medias being addictive, I believe they're addictive. There are legitimate academics that will debate me on that, and I'm happy to join that debate. But as I said before, it's a tough argument to win when people spending upwards of 10 to 16 hours a day doing it. I don't know what you call that besides addictive. We can argue about what percentage are doing that, but nevertheless, once you accept something as addictive, for other addictive things we immediately age gate it above 18 or 21, right? Mm-hmm. We don't believe that the teenagers have the ability to regulate their alcohol or tobacco or gambling, all of which we accept are addictive. In fact, in the case of alcohol, we raised the age from 18 to 21 because we thought even 18-year-olds weren't able to do it. And yet somehow for this behavior, we think of it as just so different that it doesn't require greater cognitive capacity. And I don't believe that. Yeah, very good point. Kris, let me ask you a question about how you and your colleagues at Children and Screens set priorities because there are a lot of things that one could potentially worry about as outcomes. There's violence that kids see on social media. There's cognitive and brain development, social developments, social interactions, and bullying. Mental health, body image, diet, all these things are out there. How do you decide what to work on? Well, we try to work on all of it. And in fact, we've built up a fair amount of expertise and resources around almost 25 different topics. And we also understand that, you know, childhood is a long period of time. Birth to 18, birth to 21, birth to 25, depending on who you talk to. So, we're able to take those 25 topics and also provide deeper, you might say, resources that address the different stages of development. We're really trying to do as much as we can. What's been interesting over these last few years is trying to figure out when to be reactive, when to be proactive. And by being proactive, we go out looking for the research, translating it, digesting it, and creating materials with it that we think are really accessible and actionable. At the same time, as Dimitri points out, there are policy windows and there are opportunities that present themselves that you have to react to. If you just only talk about what you want to talk about to each other you're missing some of these external opportunities to inform policy and policy makers. Help influence the way that parents and providers are talking about the issue. Framing it in such a way that engages youth and makes them want what we want for them. We're really excited by increasing opportunities to partner in coalitions with others that care about kids and teachers and nurses and doctors. But we also are speaking directly to leaders in states and school districts at the federal level, at the local level. You would be, I'm sure, not surprised to hear that we are contacted every day by groups that support parents and families. Asking for resources, asking for support, because they're seeing the impact now over many years on their children, their development. Their academic ability. Their cognitive and analytical ability. Their social emotional ability. Their ability to pay attention to tasks that we all know are critical in building that foundation for essentially, you know, future success. The Institute is being pulled in many directions. Ee try really hard to be strategic about what are people asking us for? What does the research say and how can we get that to them as quickly as possible? Dimitri - Can I add to that? You know, I want to emphasize that the concern around the effects of screen use on children's lives is shared by parents on both sides of the aisle. 75% of parents are concerned about the impact of screens on their children's lives. 35% of teenagers are concerned about their dependents on screens and that it has a negative effect on their lives. Actually by some studies, some surveys, even more than 35 to 50% of teenagers are concerned. And both sides of the political aisle agree in large part of this. And Kris and Kelly, you guys are the policy wonks, you can speak more to that. So it's a serious indictment on us as grownups and as a society that we have not done more to deliver on this issue. Why? When there's bipartisan agreement amongst many policymakers. This is not a political [00:22:00] issue to speak of and there is widespread concern on the part of parents and even teenagers. Why is nothing happening? Well, one has to look no further than where the money is. And that's a problem. I mean, that's a serious indictment on our political system when we can't deliver something that is needed and basically wanted by everybody but the industry itself. We'll come back and talk in a few moments about the policy issues and where industry gets involved here. But let me take just a bit of a detour from that and talk about the book that I mentioned earlier, because I think it's such a valuable resource. Now, when I mention the name of this book I'm urging our listeners to write this down or to remember it because you can get the book at no cost. And I'll come back, Kris, and explain what made that possible and why the decision was to make this an open access book. But Dimitri, let's begin with you. So you, along with Lauren Hale, edited this book that's entitled, The Handbook of Children and Screens: Digital Media Development and Wellbeing From Birth Through Adolescence. I think it's an extraordinary piece of work, but tell, tell us about the book.  It was an extraordinary undertaking. There's I think 178 or 180 authors. Literally, it's a who's who of experts in children and media research in all disciplines. It represents pediatrics, psychiatry, psychology, communications experts, demography, lawyers, neuroscientists. I don't know who I'm forgetting. Every single discipline is represented. Leading scientists in all of those areas. Virtually every topic that someone might be of interest to people. And we deliberately made the chapters short and easily accessible. So, it is, I think, a great resource for the constituents we serve. For teachers, for parents, for researchers, for policymakers. And it is free. The hardest part of it, to be honest, as an editor, was getting peer reviewers because unfortunately, every expert was conflicted since they all had an article in it. But it was a long time coming. And again, this was really the brainchild of Pam (Pamela Hurst-Della Pietra) and we're grateful to have brought it along. So, you go all the way from the neuroscience, how children's brains are reacting to this, all the way out there into the public policy and legal arena about what can be done about it. And then kind of everything in between. It's remarkable how much the book covers. It's almost a thousand pages. I mean, it is a tome to be sure. And don't forget to mention, Dimitri, we aren't even two months post publication, and we have 1.6 million views of the document, despite its gargantuan size. I think that is really a tribute to experts like you and others that have really studied this issue and can speak directly to its impacts. It's been great to see the success so far. You know, not a small number of those views is from me logging on. And then a million from me and then we got there. So, it is free because it's online and you can download it. You can also order a hard copy for I think, $60, but I'm not sure why you would do that if you can download it for free. But it's up to you. So, Kris, it's unusual for a book like this to be made open access and free to the general public. What made that possible and why was that so important? We want the maximum number of people to use it and treat it like the premier resource that it is. And the only way you can really do that is to fund it to be open access and find a publisher that does open access publishing, which we did with Springer. I mean, most journal articles are behind a paywall and publishers do require you to purchase either a subscription or the document itself to download it or order it. And we just really wanted maximum access. So, we funded it to be published in that way. And I think honestly, it helped us even sort of create it in the first place. People want to be a part of something that has that level of access and is available so widely. So, I think it was a kind of mutually beneficial. It gets more people to read it, but it got more people to write for it too, I think. Right, Dimitri? Dimitri - I agree. I mean, you know, the numbers 1.6 million are extraordinary. I mean, Kelly, you've been internal editor. I mean, as a editor of JAMA Pediatrics, if an article gets 70,000 views, it's in our top 1%, you know, 200,000 views is 0.01%. 1.6 million in growing is really extraordinary. And that's about the number of people that read my articles. 1.6. And of course, they're not all scientists. I mean, many of them are parents and maybe are policy makers, but that's Kris's point, you know. The moment anyone hits a paywall, even if it's a dollar or two, they're going to walk away. It's great to see it get so much traction. Alright, so again, for our listeners, the title of the book is The Handbook of Children and Screens. And it's really a terrific resource. Alright, so let's turn our attention to a really important matter. And we've sort of touched on this, but who's in charge of protecting our children? You know, Dimitri at the end of the day help survey this landscape for us. I mean, is it congress, is it the administrative branch of government? What role do the courts play? Are there legal actors taking meaningful action? What's being done does it come anywhere near, meeting the need. Tell us about what that landscape is like? Well, there isn't adequate protections for children. And we talked a little bit about that earlier. There's been an enormous loophole, unfortunately, created by Congress when they added the Section 230 to the Communications Decency Act in 1996. And that was put in place essentially to provide protections for internet companies. And it basically said that they should be treated like bookstores and not publishers. That they weren't responsible for content they were just conveying it. And what that means, in effect, was that the companies had sort of carte blanche to do whatever they want. And they've used that very effectively, legally, to argue that any restriction, any culpability on their part, is protected by that Act. That they're exonified for any ill that occurs as a result of their product. The only exception that's been made of it, to date, was around sex trafficking on back page, if anyone remembers that. But other than that, social media sites and internet sites in general have been able to say that they're not liable for anything that's done. And I think that was a huge mistake that was made. It needs to be rectified. It's being challenged in the courts presently. My own belief is that, and I'm not speaking as a lawyer, is that when that law was passed, it was under the assumption as I said, that they were just conveying information. No one at the time foresaw the development of algorithms that would feed the information. It's really not a bookstore when you are making recommendations. Once you start recommending things, I think you're no longer merely a purveyor of product. You're actually pushing it. So, Kris, tell us about the Children and Screens and the role the organization plays in this space. And how do you deal with policy and is it possible to be bipartisan? Yeah, I mean, it's essential. There's no way to get anything done, anywhere on these policy matters at a population level without working in a bipartisan or non-partisan manner, which is what we've always done. And it's easy to do that when you're following the science, not ideology. And you're putting the science first and you're creating resources and tools and support for those mostly staffers, honestly, that are trying to help their bosses get smarter and better at talking about these issues as they evolve and become more complicated over time. It takes more effort to staff a lawmaker on this front. And they're very anxious to learn and understand because they're meeting with parents of children who have been harmed. Or frankly didn't even survive their childhood because of the social media platform. There's great urgency on the part of policymakers. We've heard everything from school phone bans to outright social media bans proposed as policies. And one thing I like to come back to is it's one thing to want to take action and make your best guess at what would have the best impact. But it's another thing to study whether or not that policy actually achieved its result. And it's a part of this that by staying bipartisan, nonpartisan allows us to say, 'Hey lawmaker, if you're able to get that to happen, we'd really like to come in and help study whether or not your idea actually achieves the results that you wanted, or if it needs to be adjusted or amended over time.' Fantastic. That's so important to be doing that work, and I'm delighted the organization is doing it. Let me ask a question here. If you think about some of the areas of public health that I've been following, like tobacco, for example. Opioids more recently. Vaping products. And in the case of my own particular work food policy. The administrative legislative branches of government have been almost completely ineffective. If I think about food policy over the years, relatively little has been accomplished. Even though lots of people have worked really hard on it. Same thing happened with tobacco for many years. Opioids, same thing.  And it's until you get the third branch of government involved, the judiciary, and you start suing the actors who were causing the harm do you get much action. Not only do the lawsuits seem to have an effect, but they soften the ground for legislative things that then can occur because public opinion has changed. And then those things help make a difference as well. What do you think about that kind of issue in this space?  I think you're exactly right. I mean, I think the failure of our legislative branch to enact policy leaves us with very few options at this point anyway, except to try to pursue it through the judiciary. There are challenges there. First and foremost, it's a big and well-funded industry, not unlike tobacco or big food, as you mentioned and there's this Section 230 that's given them kind of blanket immunity to date. But there are many, many very large pending cases in several jurisdictions brought by individuals, brought by school districts, brought by states. And those, at least provisionally have gotten further than prior cases have with which have been thrown out based on Section 230. So, we'll see what happens with that litigation. But right now, my guess is it's the best chance we have to set some guardrails. And I think there are plenty of guardrails that could be set. Everything that these companies have done to make their products addictive can be undone. Can be made protective. The tobacco company deliberately designed their products to be addictive. While they tried to make the claims that they were less addictive, you know. They made light cigarettes that had holes in the filter so that it would diffuse the carbon and nicotine, but people quickly learned they could cover those up with their fingers and think they were smoking light cigarettes, and smoke more of them. There's a lot of things that can be done in this space to undesign the problematic nature of the products. And quite apart from the financial settlements, which will get companies attention, I hope that that's part of any settlement if it gets that far. It'll be interesting to see where those go. And, also historically, one important part of these lawsuits is what gets turned up in discovery. And what sort of intent the companies have and how much do they know about harms. And how much do they know about addiction and things like that. And how they might have proceeded in the face of that information that then doesn't get disclosed to the public. In any event, we'll see where that goes. Dimitri, what about the argument that responsibility resides with parents. It's up to parents to protect their kids from this, and government doesn't need to be involved. I've never understood that argument. I mean parents obviously are children's most important safeguard, but as a society, we enact policies and laws to assist parents in that. I mean to me, if I made the argument, well, why, why do we have minimum ages of drinking. It's parents' job to make sure their kids don't drink. How would that possibly play out? Look, it's hard enough as a parent anyway, because kids do get around these laws. But we still have them and it's a lot easier as a parent. I think most parents would agree their life's made easier by minimum age restrictions on certain things. We have seatbelt laws. I mean, why do we have seatbelt laws? Why don't we just tell its parents' job to make sure their kids buckle up? The truth is its society and parents working hand in hand to try and keep children safe. And I think it also helps parents to be able to say that there are laws around this, and I expect you to follow the laws. So, I don't think it's an either or. Okay, well, I think that's a very good way to frame it. There are many, many precedents where we protect children. And why not do it here too? So let me end with a question I'd like to ask both of you. So, in this sea of concerns that we've discussed, is there a reason for optimism? And Kris, let me start, start with you. What do you think? Absolutely. I think the young people I've met that are leading among their peers are incredibly impressive and are armed with the research and their energy and their own lived experience in ways that are very compelling. At the same time, I think the vast amount of research that has now been compiled and translated and acted upon, whether in courtrooms or in state houses, it's becoming more, and we're all getting more steeped and aware of more nuanced information. And finally, I would just say, there is a tipping point. We are reaching as a society, adults and kids alike, we are reaching a tipping point where we can't withstand the pressure of technology in every aspect, every corner of our day, our life. And we want relief. We deserve relief. And I think that's what's going to take us over the finish line. Good. Well, I'm glad to hear those optimistic notes. Dimitri, what about you? I can find reasons to be optimistic. I mean, look, the reality is that technologies have enriched our lives in many ways. And I think if we put guardrails in place, we can make sure that future ones do even better. I have a piece coming out in JAMA Pediatrics around the use of AI, which people are very concerned about, I think rightly. But specifically, about the use of AI and people with intellectual developmental disabilities, making the use case, that there are ways in which it could be extremely beneficial to that population. A population I care deeply about in my role as the Chief Health Officer at Special Olympics International. And in particular, let's say in terms of the doctor patient interaction where it could facilitate their communication with their provider, and it could also help the provider better communicate with them. Look, that use case isn't going to be a priority for the purveyors of artificial intelligence. It's a small, non-lucrative use of a technology. But it's a good one. And if we created the right incentives and put in the right guardrails, we could find many other ways that technology can serve the needs of all of us going forward. I think the problem is that we've tended to be reactive rather than proactive. And to not start with the do no harm first premise, particularly when it comes to children. AI is another example of that where I hope we don't make the same mistake we made with social media. Bios Kris Perry is the executive director of the Children and Screens Institute. Kris most recently served as Senior Advisor to Governor Gavin Newsom of California and Deputy Secretary of the California Health and Human Services Agency where she led the development of the California Master Plan for Early Learning and Care and the expansion of access to high-quality early childhood programs. She led systems change efforts at the local, state and national levels in her roles as executive director of First 5 San Mateo, First 5 California and of the First Five Years Fund. Through it all, Perry has fought to protect children, improve and expand early learning programs, and increase investments in low-income children. Perry was instrumental in returning marriage equality to California after the landmark 2013 U.S. Supreme Court ruling Hollingsworth v. Perry, which she wrote about in her book Love on Trial (Roaring Forties Press, 2017). Dimitri Christakis, MD, MPH is the Children and Screens Institute's inaugural Chief Science Officer. He is also the George Adkins Professor at the University of Washington, Editor in Chief of JAMA Pediatrics, and the Chief Health Officer at Special Olympics International. Christakis is a leading expert on how media affects child health and development. He has published over 270 peer reviewed articles (h-index 101) including dozens of media-related studies and co-authored a groundbreaking book, The Elephant in the Living Room: Make Television Work for Your Kids. His work has been featured on Anderson Cooper 360, the Today Show, ABC, NBC, and CBS news as well as all major national newspapers. Christakis received his undergraduate degree at Yale University and his medical training at the University of Pennsylvania School of Medicine and completed his residency and Robert Wood Johnson Clinical Scholar Fellowship at the University of Washington School of Medicine. 

Stand Up is a daily podcast that I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 700 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more Dr. Aaron E. Carroll is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all.  Before joining AcademyHealth, Dr. Carroll was a Distinguished Professor of Pediatrics and Chief Health Officer at Indiana University, where he also served as Associate Dean for Research Mentoring and the director of the Center for Pediatric and Adolescent Comparative Effectiveness Research at Indiana University School of Medicine. He earned a B.A. in chemistry from Amherst College, an MD from the University of Pennsylvania School of Medicine, and an M.S. in health services from the University of Washington School of Public Health, where he was also a Robert Wood Johnson Clinical Scholar. Dr. Carroll's research focused on the study of information technology to improve pediatric care, decision analysis, and areas of health policy including cost-effectiveness of care and health care financing reform. He is the author of The Bad Food Bible and the co-author of three additional books on medical myths. In addition to having been a regular contributor to The New York Times and The Atlantic, he has written for many other major media outlets and is co-Editor-in-Chief at The Incidental Economist, an evidence-based health policy blog. He also has a popular YouTube channel and podcast called Healthcare Triage, where he talks about health research and health policy. Join us Thursday's at 8EST for our Weekly Happy Hour Hangout!  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing Gift a Subscription https://www.patreon.com/PeteDominick/gift

Stand Up is a daily podcast that I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 700 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more GET TICKETS TO PODJAM II In Vegas March 27-30 Confirmed Guests! Professor Eric Segall, Dr Aaron Carroll, Maura Quint, Tim Wise, JL Cauvin, Ophira Eisenberg, Christian Finnegan and The Ladies of The Hue will all join us!   Dr. Aaron E. Carroll is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all.  Before joining AcademyHealth, Dr. Carroll was a Distinguished Professor of Pediatrics and Chief Health Officer at Indiana University, where he also served as Associate Dean for Research Mentoring and the director of the Center for Pediatric and Adolescent Comparative Effectiveness Research at Indiana University School of Medicine. He earned a B.A. in chemistry from Amherst College, an MD from the University of Pennsylvania School of Medicine, and an M.S. in health services from the University of Washington School of Public Health, where he was also a Robert Wood Johnson Clinical Scholar. Dr. Carroll's research focused on the study of information technology to improve pediatric care, decision analysis, and areas of health policy including cost-effectiveness of care and health care financing reform. He is the author of The Bad Food Bible and the co-author of three additional books on medical myths. In addition to having been a regular contributor to The New York Times and The Atlantic, he has written for many other major media outlets and is co-Editor-in-Chief at The Incidental Economist, an evidence-based health policy blog. He also has a popular YouTube channel and podcast called Healthcare Triage, where he talks about health research and health policy. Join us Thursday's at 8EST for our Weekly Happy Hour Hangout!  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing Gift a Subscription https://www.patreon.com/PeteDominick/gift      

What’s Trending: The Lake Washington School District is under Federal investigation for allegedly allowing and even supporting antisemitism. Media Bias: Mediaite’s coverage of a joke made by JD Vance is making it seem like he is slandering Kamala Harris. The executive institute that held an office standoff against DOGE, the United Institute of Peace, is “on the right path” after a judge’s court order. Actress Gal Gadot’s Hollywood Walk of Fame ceremony was delayed by Anti-Israel protesters. // Big Local: New annexation scenarios proposed would make Vancouver the second biggest city in the state. An elderly Tacoma man is in the hospital after the Tacoma authorities towed the vehicle that he was sleeping in. And a driver in Edmonds is under arrest after crashing into Caraban Kebab and Salon Meow. // You Pick the Topic: Jeopardy! Fans are distraught after what seemed like an easy pop-culture question left competitors stumped.

In this episode of MedNews Week's Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, spoke with Petros Grivas, MD, PhD, clinical director of the Genitourinary Cancers Program at Fred Hutchinson Cancer Center and a professor of medicine at the University of Washington School of Medicine, about key updates from the 2025 Genitourinary Cancers Symposium and the evolving treatment paradigm for muscle-invasive bladder cancer (MIBC).

Emergency treatment may be necessary after a person's first seizure or at the onset of abnormal acute repetitive (cluster) seizures; it is required for status epilepticus. Treatment for these emergencies is dictated by myriad clinical factors and informed by published guidance as well as emerging research.   In this episode, Lyell K. Jones, MD, FAAN, speaks with David G. Vossler, MD, FAAN, FACNS, FAES, author of the article “First Seizures, Acute Repetitive Seizures, and Status Epilepticus,” in the Continuum® February 2025 Epilepsy issue. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Vossler a clinical professor of neurology at the University of Washington School of Medicine in Seattle, Washington. Additional Resources Read the article: First Seizures, Acute Repetitive Seizures, and Status Epilepticus Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ  Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr Dave Vossler, who has recently authored an article on emergent seizure management, taking care of patients with the first seizure, acute repetitive seizures, and status epilepticus, which is an article in our latest issue of Continuum covering all topics related to epilepsy. Dr Vossler is a neurologist at the University of Washington, where he's a clinical professor of neurology and has an active clinical and research practice in epileptology. Dr Vossler, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners? Dr Vossler: Thank you very much for the introduction, Lyell. It's a pleasure to speak with you on this podcast, and I hope to go over a lot of important new information in the management of seizure emergencies. As you said, I'm a clinical professor in neurology at University of Washington, been in medicine for many decades now and have published and done research in this area. So, I'm anxious to give you not only my academic experience, but also talk about my own management of patients with status epilepticus over the last four decades. Dr Jones: Yeah, that's fantastic. And I always appreciate hearing from experienced clinicians, and I think our readers and our listeners do appreciate that voice of clinical expertise. And I'll tell you this is a topic, you know, as a neurologist who doesn't see many patients with acute seizure emergencies in my own practice, I think this is a topic that gives many clinicians, including neurologists, some anxiety. Your article, Dr Vossler, is really chock-full of helpful and clinically relevant considerations in the acute management of seizures. So, you now have the full attention of a huge audience of mostly neurologists. What's the one most important practice change that you would like to see in the care of patients with either first or acute prolonged seizures? Dr Vossler: Without a doubt, the most important clinical takeaway with regard to the status epilepticus---and for status epilepticus, many, many clinical trials, research trials have been done over the last couple decades and they all consistently show the same thing, that by and large most patients who have status epilepticus are underdosed and undertreated and treated too slowly in the initial stages of the status epilepticus. And it's important to use full bolus dosages of benzodiazepines to prevent mortality, morbidity, and later disability of these patients. To prevent the respiratory depression, many physicians are afraid to use higher doses of benzodiazepines, even guideline-recommended doses of benzodiazepines for fear of respiratory depression. But it's actually counterintuitive. It turns out that most cases of respiratory depression are due to inadequate doses and due to the status epilepticus itself. We know there's greater mortality, we know there's greater morbidity and we know that there's greater need for higher dose, subsequent, anti-seizure medications, prolonged status, if we don't use the proper doses. So, we'll kind of go over that a little bit, but that is the one clinical takeaway that I really would like our listeners to have. Dr Jones: Let's follow that thread a little bit. Dave, I know obviously we will speak in hypotheticals here. We're not going to talk about actual patients, but I think we've all been in the clinical situation where you have a patient who comes into the emergency room usually who's actively seizing, unknown history, don't know much about the patient, don't know much about the circumstances of the onset of the seizure. But we now have a patient with prolonged convulsive seizures. How do we walk through that? What are the first steps in the management of that patient? Dr Vossler: Yeah, well, I'll try to be brief for the purposes of the podcast. We do, of course, go through all of that in detail in the Continuum article, which hopefully everybody will look at very carefully. Really in the first table, the very first table of the article, I go through the recommended guideline for the American Epilepsy Society on the management of what we call established status epilepticus. The scenario you're talking about is just exactly that: established status epilepticus. It's not sort of evolving or developing status. We're okay they're having a few seizures and we're kind of getting there. No, this patient is now having evidence of convulsive seizure activity and it's continuing or it's repeated seizures without recovery. And so, the first phase is definitely a benzodiazepine and then the second phase is then a longer-acting bolus of a drug like phosphenotoine, valproic acid or levetiracetam. I could get into the details about dosing of the benzodiazepines, but maybe I'll let you guide me on whether we wanted to get into that kind of detail right at the outset. It's going to be a little bit different. For children, its weight-based dosing, but for adults, whether you use lorazepam or you use diazepam or you use midazolam, the doses are a little bit different. But they are standardized, and gets back to this point that I made earlier, we're acting too slow. We're not getting these patients quick enough, for various reasons, and the doses that are most commonly used are below what the guidelines call for. Dr Jones: That's great to know, and I think it's fine for the details to refer our listeners to the article because there are great details in there about a step-by-step approach to the established status epilepticus. The nomenclature and the definitions have evolved, haven't they, Dr Vossler, over time? Refractory status epilepticus, new-onset refractory status epilepticus, super refractory status epilepticus. Tell us about those entities, how they're distinguished and how you approach those. Dr Vossler: That's an important thing to kind of go over. They- in 2015, the International League Against Epilepsy, ILAE, which is, again, our international organization that guides our understanding of all kinds of things epileptic in nature around the world. In 2015 they put out a definition of status epilepticus, but it used to be that patients had thirty minutes of continuous seizure activity or repetitive obvious motor seizures with impairment of awareness and they don't recover impairment between these seizures. And that goes on for thirty minutes. That was the old definition of status epilepticus. Now, the operational definition is five minutes. And I think that's key to understand that, after five minutes of this kind of overt seizure activity, you need to intervene. And that's what's called T1 in the 2015 guideline, the international guideline. There are a bunch of different axes in the classification of status that talk about semiology, etiology, EEG patterns, and what age group you're talking about. We won't really get into those in the Continuum article because that's really more detailed than a clinician really should be. Needing to think about the stages, what we call the stages of status epilepticus that you mentioned and I alluded to earlier are important. And that is sort of new nomenclature, and I think probably general neurologists and most emergency room physicians aren't familiar with those. So, it just briefly goes through those. Developing status epilepticus is where you're starting- the patient's starting to have more frequent seizures, and it's heading essentially in the wrong direction, if you will. Established status epilepticus, as I mentioned, is, you know, this seizure act, convulsive or major, major outward overt seizure activity lasting five minutes or more, at which time therapy needs to begin. Again, getting back to my point, what doesn't happen often enough is we're not- we're intervening too late. Third is refractory status epilepticus, which refers to status epilepticus which continues despite adequate doses of an initial benzodiazepine given parenterally followed by a full loading dose of a single non-sedating anti-seizure medicine, which today includes phosphenotoine IV valproic acid or IV levetiracetam. In the United States, and increasingly around the world, people really are using levetiracetam. First, it has some advantages. There's now proof from a class one NIH-funded trial. We know that these three drugs are equivalent at the full doses that I go over in the article. You have your kind of dealer's choice on those. Phenobarbital, which we used to use and I used as a resident as long as forty years ago, is really a second choice drug because of its sedating and other side effects. But around the world in resource-poor countries phenobarbital can be used and, in a pinch, certainly is an appropriate drug. And then finally, you mentioned super refractory status epilepticus and that's status that's persisting for more than twenty four hours. Now, despite initial benzo and non-sedating anti-seizure medicine, but also lasting more than twenty four hours while receiving an intravenous infusional sedating, anesthetizing anti-seizure medicine like ketamine, propofol, pentobarbital or midazolam drips. Dr Jones: So, it sounds like the definitions have evolved in a way that improves the outcomes, right? To do earlier identification of status epilepticus and more aggressive management, I think that's a great takeaway. If we move all the way to the other end of the spectrum, let's move to the ambulatory setting and we have a patient who comes in and they've had one seizure, they're an adult; one seizure, the first seizure. The key question is, how do we anticipate the risk of future seizures? But walk us through how you talk to that patient, how you evaluate that patient to decide if and when to start anti-seizure medicines. Dr Vossler: Well, it depends a little bit if it's an adult or a child, but the decision making process and the data behind it is pretty robust now. And the decision making process is pretty similar for adults and children, with some differences which I can talk about. First of all, first seizures. I think it's really important to stress that there's been so much research in this area. I'd like to get a cross point that they're not as innocuous as I think many general neurologists might suspect. We know that there is a two- to threefold increased risk of death in children and adults following a first seizure. Moreover, the risk of a second seizure, both in kids and adults, is about 36% two years after that first seizure. It's about 46% five years after that first seizure. It's really pretty substantial. The risk of a second seizure is increased twofold. It doubled in the presence of any kind of a history of prior brain insults that could result in seizures. Could be infections, it could be a prior stroke, it could be prior significant brain trauma. It's also doubled in the presence of an EEG, which shows epileptiform discharges like spikes and sharp waves---and not just a sort of borderline things like sharply contoured rhythmic Theta activity. That's really not what we're talking about. We're talking about overt epileptiform discharges. It's doubled in the presence of lesion that can be seen on imaging studies, and it's doubled in the presence of seizures if that first seizure occurs during sleep. So, we have a number of things that double the risks, above the risk of a second seizure, above that 36% at two years and 46% at five years that I spoke about. And so those things need to be considered when you're counseling a patient about that. Should you be on an anti-seizure medicine after that first seizure? Specifically, to the point of anti-seizure medications, the guideline that was done, the 2015 guideline that was done by the American Academy of Neurology for adults, and the 2003 guideline was actually a practice parameter that was done by the Academy and the American Epilepsy Society for children, are really kind of out of date. They talk about the adverse effects of anti-seizure medications, but when you look back at the studies that were included in developing that practice parameter for kids and guidelines for adults, they are the old drugs: carbamazepine, phenytoin, phenobarbital and valproate. Well, I don't think I need to tell this audience, this well-educated audience, that we don't use those drugs anymore. We are using more modern anti-seizure medicines that have been developed since 1995; things like lamotrigine, levetiracetam, and lecosamide. Those three in particular have very low adverse events. So, the guideline that the Academy, American Academy Neurology and American Epilepsy Society put together for kids and for adults talks about this high adverse event profile. And so, you need to take a look at the risks that I talked about of a seizure recurrence and balance that against adverse effects. But I'm here to tell you that the newer anti-seizure medicines---and by newer I'm talking in the last thirty years since lamotrigine was approved in 1995---these drugs have much better side effect profiles. And I think all epileptologists would agree with that. They're not necessarily more effective, but they are better tolerated. That makes the discussion of the risk of a second seizure, the risk of mortality versus side effects of drugs, it really pushes the risk category higher on the first side and not on the side of drugs. We know that if you take an anti-seizure medicine, you reduce your risk of a second seizure by half. Now, that's not sustained over five years, but over the first two years, you've reduced it by half. In a person who's driving, needs to get to work, has to take the kids to school, whatever, most of my patients are like, yeah, okay, sign me up. These drugs are really pretty well tolerated. There's a substantial risk of a second seizure. So, I'll do that. In a kid,  a child that's, you know, not driving yet, that might be a different discussion. And the parents might say, well, I'd rather not have my son exposed, my daughter exposed to this. They're trying to go to school. They're trying to learn. We don't want to hinder that. We'll wait for a second seizure and then if they have a second seizure, which by the way is, you know, one of the definitions of epilepsy, well then they have epilepsy, then they probably will need to go on the seizure medication. Dr Jones: Great summary, Dr Vossler, and it is worth our audience being aware that the evidence has evolved alongside the improvement in the adverse effect profile. And sounds like your threshold is a little lower to treat then maybe it would have been some time ago, right? Dr Vossler: I would say that's exactly correct in my opinion. Particularly for adults, absolutely. Dr Jones: That's fantastic, Dr Vossler. I imagine there are a lot of aspects of caring for these patients that are challenging, and I imagine many scenarios are actually pretty rewarding. What do you find the most rewarding aspect of caring for patients with acute seizure management? Dr Vossler: Yes, I mean, that is really true. I would say that the most challenging things are treating refractory status epilepticus, but worse yet, new onset refractory status epilepticus and the super refractory status epilepticus, which I talk extensively about or write extensively about in the article and provide a lot of guidance on. Really, those conditions are so challenging because they can go on for such a long time. Patients are hospitalized for a long time. A lot of really good clinical guidance doesn't exist yet. There is a tremendous amount of research in that area which I find exciting, and really there's an amazing amount of international research on that, I think most of our audience probably is unaware of. And certainly, with those conditions, there is a high risk of later disability and mortality. We go through all of that in the article. The rewards really come from helping these people. When someone was super refractory status and it were non- sorry, new onset refractory status epilepticus, has been in the hospital for thirty days, it gets really hard for everybody; the family, the patient. And for us, it wears on us. Yet when they walk out the door, and I've had these people come back to the epilepsy clinic and see me later. We're managing their anti-seizure medications. They've survived. The NORSE patients often have substantial disability. They have cognitive and memory and even some psychiatric disability. But yet we can help them. It's not just management in the hospital, but it's getting to know these people, and I take them from the hospital and see them in my clinic and manage them long-term. I get a lot of great satisfaction out of that. We're hoping to do even better, stop patients' status early and get them to recover with no sequelae. Dr Jones: What a great visual, seeing those patients who have a devastating problem and they come back to clinic and you get the full circle. And what a great place to end. Dr Vossler, thank you so much for joining us, and thank you for such a thorough and fascinating discussion on the importance of understanding and managing patients with the first seizure, acute repetitive seizures, and status epilepticus. Dr Vossler: Thank you very much, Lyell. Dr Jones: Again, we've been speaking with Dr Dave Vossler, author of an article on emergent seizure management, first seizures, acute repetitive seizures and status epilepticus in Continuum's most recent issue on epilepsy. Please check it out, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speaking with Dr. Kathleen Moore about HRD testing in ovarian cancer and its clinical significance in helping aid precision medicine approaches.   Dr. Kathleen Moore is a Professor of Gynecologic Oncology at the University of Oklahoma Health Sciences Center, Associate Director of Clinical Research and Director of the Oklahoma TSET Phase I Program at the Stephenson Cancer Center. A graduate of the University of Washington School of Medicine, WA, Dr. Moore completed her residency in gynecology at the University Health Center of Pittsburgh in Pittsburgh, PA and completed a fellowship in gynecologic oncology at the University of Oklahoma College of Medicine in Oklahoma City, OK. She is board certified in obstetrics and gynecology as well as gynecologic oncology and hospice and palliative care.   For more information, visit: https://www.azprecisionmed.com/tumor-type/ovarian-cancer/hrd-testing.html For patient resources, please visit TestForHRD.com.   This podcast does not necessarily reflect the opinions of AstraZeneca and are the spokeperson's opinions and experience.

In this episode of Oncology Unplugged, a podcast series from OncLive and MedNews Week, podcast host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was joined by Petros Grivas, MD, PhD; and Ruben Raychaudhuri, MD, to talk about a pilot trial investigating neoadjuvant accelerated methotrexate, vinblastine,doxorubicin, and cisplatin (aMVAC) plus pembrolizumab (Keytruda) in patients with non-urothelial muscle-invasive bladder cancer, findings from which were presented at the 2025 Genitourinary Cancers Symposium. Dr Grivas is clinical director of the Genitourinary Cancers Program and a professor in the Clinical Research Division at Fred Hutchinson Cancer Center, as well as a professor in the Division of Hematology and Oncology at the University of Washington School of Medicine in Seattle. Dr Raychaudhuri is an assistant professor in the Clinical Research Division at Fred Hutchinson Cancer Center, as well as an assistant professor in the Division of Hematology and Oncology at the University of Washington School of Medicine. In their exclusive conversation, Drs Park, Grivas, and Raychaudhuri discussed key efficacy and safety findings from this study; the need for conducting dedicated research in bladder cancer patient populations with variant histologies; and the potential of biomarkers, such as HER2 expression, to improve the bladder cancer treatment paradigm in the future.

In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we’re speaking with Dr. Kathleen Moore about HRD testing in ovarian cancer and its clinical significance in helping aid precision medicine approaches. Dr. Kathleen Moore is a Professor of Gynecologic Oncology at the University of Oklahoma Health Sciences Center, Associate Director of Clinical Research and Director of the Oklahoma TSET Phase I Program at the Stephenson Cancer Center. A graduate of the University of Washington School of Medicine, WA, Dr. Moore completed her residency in gynecology at the University Health Center of Pittsburgh in Pittsburgh, PA and completed a fellowship in gynecologic oncology at the University of Oklahoma College of Medicine in Oklahoma City, OK. She is board certified in obstetrics and gynecology as well as gynecologic oncology and hospice and palliative care. For more information, visit: https://www.azprecisionmed.com/tumor-type/ovarian-cancer/hrd-testing.html For patient resources, please visit TestForHRD.com. This podcast does not necessarily reflect the opinions of AstraZeneca and are the spokeperson's opinions and experience.

In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we’re speaking with Dr. Kathleen Moore about HRD testing in ovarian cancer and its clinical significance in helping aid precision medicine approaches. Dr. Kathleen Moore is a Professor of Gynecologic Oncology at the University of Oklahoma Health Sciences Center, Associate Director of Clinical Research and Director of the Oklahoma TSET Phase I Program at the Stephenson Cancer Center. A graduate of the University of Washington School of Medicine, WA, Dr. Moore completed her residency in gynecology at the University Health Center of Pittsburgh in Pittsburgh, PA and completed a fellowship in gynecologic oncology at the University of Oklahoma College of Medicine in Oklahoma City, OK. She is board certified in obstetrics and gynecology as well as gynecologic oncology and hospice and palliative care. For more information, visit: https://www.azprecisionmed.com/tumor-type/ovarian-cancer/hrd-testing.html For patient resources, please visit TestForHRD.com. This podcast does not necessarily reflect the opinions of AstraZeneca and are the spokeperson's opinions and experience.

Conan talks to Aadithya (Aadu) about working as a research engineer at the University of Washington School of Oceanography, his upcoming wedding, and the birds he associates with Conan, Matt, and Sona. Wanna get a chance to talk to Conan? Submit here: teamcoco.com/apply Get access to all the podcasts you love, music channels and radio shows with the SiriusXM App! Get 3 months free using this show link: https://siriusxm.com/conan.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.The video mentioned in this episode that further explains situational tolerance can be found at https://gordie.studenthealth.virginia.edu/learn/alcohol-education/situational-tolerance (created by Dr. Susie Bruce and her team at the Gordie Center). This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.The video mentioned in this episode that further explains situational tolerance can be found at https://gordie.studenthealth.virginia.edu/learn/alcohol-education/situational-tolerance (created by Dr. Susie Bruce and her team at the Gordie Center). This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

In this series we talk with Dr. Jason Kilmer, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. He specializes in the development, implementation, and evaluation of substance use prevention and intervention efforts on college campuses and among 18–25 year olds.   While Dr. Kilmer focuses on college campuses, his insights are universal and particularly helpful for parents with teenagers of any age. Share these recordings with your parenting peers as you all navigate this exciting time in human development (ages 14–25) and work to help your kids navigate away from alcohol and other drugs.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.This podcast is brought to you by the Substance Abuse and Mental Health Services Administration (SAMHSA). The views expressed here are not necessarily those of SAMHSA or the U.S. Department of Health and Human Services. For questions or comments about this podcast, please contact WhatParentsAreSaying@gmail.com.

David James Clark, DDS, joins with Dr. George Schmidt during the latest podcast episode. Dr. Clark explains the art and science of monolithic injection-molded composite dentistry and talks about utilizing injection-molding of composites with modern preparations, super-anatomic clear matrices and heated multi-viscosity composite to solve so many problems without resorting to crowns. (Dr Clark is a speaker at AGD's upcoming scientific session in Montreal, July 9-12.) Dr. Clark is director of Bioclear Learning Centers International. He founded the Academy of Microscope Enhanced Dentistry, creates curriculum for dental schools and has lectured in 25 countries. He developed the Bioclear Matrix System for placement of biologically appropriate and esthetically pleasing direct composite restorations for facilitating injection-molding of the Clark Class I and Class II preparations, diastema closure, and black triangle elimination combined with papilla regeneration. The Clark Class I and Class II preparations and restorations are now being evaluated in in vivo and in vitro studies. He owns several patents. He published the first guide to dentinal and enamel cracks based on clinical microscope dentistry (16× magnification). Clark is a 1986 graduate of the University of Washington School of Dentistry.

Thursday, February 13 on Urban Forum Northwest :*Prakash Gupta, Counsel General, Seattle India Consulate reflects on the 75th Anniversary of the Republic of India that was observed January 26 at Bell Harbor on Seattle's waterfront and he hosted a Business Forum the next day. The Seattle Consulate was opened on February 23, 2024.*Hayward Evans, Co Convener, Seattle King County Martin Luther King Jr. Commemoration/Continuation Committee (MLKCC) comments on the organizations Black History Awards Ceremony that will be held Monday, February 17 (Presidents Day) 5:30-7:30 pm at the Holgate Street Church of Christ at Holgate Street & Martin Luther King Jr Way South in Seattle. Minister Jimmy Hurd is Pastor.*Reverend Dr. Leslie D. Braxton organized a Town Hall on Project 2025 on July 31 to highlight the devastation that the implementation would have on some the country's most vulnerable citizens, the children, the elderly, and the underserved communities. Washington State Congresswoman Marilyn Strickland and Congressman Adam Smith participated in the Town Hall.*Attorney Jesse Wineberry Sr., Co Founder, Washington Equity Now Alliance (WENA) and a former Washington State Representative has been actively involved in an effort to get Reparations legislation passed in Washington State. He authored the Draft Charles Mitchell Commission to study reparations in Washington State as an Executive Order that wasn't signed.*Gabriel Prawl, president, Seattle A. Phillip Randolph Institute (APRI) is coordinating the African American Legislative Day that will be held on Monday, February 17 (Presidents Day) in Olympia. There will be speakers from agencies, members of the legislature, and from the African American Community.*Harley Bird and Michael Woo Sr. are former leaders of the United Construction Workers Association (UCWA) they helped organize demonstrations and shut down jobs from the Seattle Tacoma International Airport, King County Administration Building, University of Washington School of Law just to name a few. All in effort to get African American workers on construction jobs.Urban Forum Northwest streams live at www.1150kknw.com. Visit us at www.urbanforumnw.com for archived programs and relevant information. Like us on facebook. X@Eddie_Rye.LikeCommentSendShare Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Thursday, February 13 on Urban Forum Northwest : *Prakash Gupta, Counsel General, Seattle India Consulate reflects on the 75th Anniversary of the Republic of India that was observed January 26 at Bell Harbor on Seattle's waterfront and he hosted a Business Forum the next day. The Seattle Consulate was opened on February 23, 2024. *Hayward Evans, Co Convener, Seattle King County Martin Luther King Jr. Commemoration/Continuation Committee (MLKCC) comments on the organizations Black History Awards Ceremony that will be held Monday, February 17 (Presidents Day) 5:30-7:30 pm at the Holgate Street Church of Christ at Holgate Street & Martin Luther King Jr Way South in Seattle. Minister Jimmy Hurd is Pastor. *Reverend Dr. Leslie D. Braxton organized a Town Hall on Project 2025 on July 31 to highlight the devastation that the implementation would have on some the country's most vulnerable citizens, the children, the elderly, and the underserved communities. Washington State Congresswoman Marilyn Strickland and Congressman Adam Smith participated in the Town Hall. *Attorney Jesse Wineberry Sr., Co Founder, Washington Equity Now Alliance (WENA) and a former Washington State Representative has been actively involved in an effort to get Reparations legislation passed in Washington State. He authored the Draft Charles Mitchell Commission to study reparations in Washington State as an Executive Order that wasn't signed. *Gabriel Prawl, president, Seattle A. Phillip Randolph Institute (APRI) is coordinating the African American Legislative Day that will be held on Monday, February 17 (Presidents Day) in Olympia. There will be speakers from agencies, members of the legislature, and from the African American Community. *Harley Bird and Michael Woo Sr. are former leaders of the United Construction Workers Association (UCWA) they helped organize demonstrations and shut down jobs from the Seattle Tacoma International Airport, King County Administration Building, University of Washington School of Law just to name a few. All in effort to get African American workers on construction jobs. Urban Forum Northwest streams live at www.1150kknw.com. Visit us at www.urbanforumnw.com for archived programs and relevant information. Like us on facebook. X@Eddie_Rye. Like Comment Send Share Learn more about your ad choices. Visit podcastchoices.com/adchoices

In the third episode of the Lifecycle series, host Jennifer Semenza speaks with Dr. Alex Hamling, pediatrician at PACMED Canyon Park-Bothell, and Clinical Instructor at University of Washington School of Medicine. He discusses essential newborn care, which ensures the baby's health and helps parents feel prepared and confident in their roles. Dr. Hamling discusses why it's essential for expecting parents to choose a healthcare provider or practice for their child in advance to avoid stress during the birthing process. While having a detailed birth plan is beneficial, flexibility is crucial, as circumstances may change to ensure a safe and healthy delivery. The conversation also provides valuable insights into current trends for caring for newborns and infants. He also talks about the health benefits of bonding and acknowledges the joy and challenges of this period. Do you want to know more?The Justice Unity Support Trust, or JUST Birth Network was created to empower and improve the birthing experience of Black, African American, African, Native American, Alaska Native, Native Hawaiian and Pacific Islander birthing women and people from across the sex and gender identity spectrum.The network includes dedicated birth and postpartum doulas, childbirth educators and inpatient cultural navigators, who provide patients and their families with expert care and guidance throughout their pregnancy and birthing experience.If you would like to know more about the role of doulas, midwives, or Type 1 Diabetes please check out these Wellness Briefs:DoulasMidwivesType 1 Diabetes Just a few of the articles on this topic from the Providence blog:How to navigate your pregnancy and newborn-related health care expensesTrouble breastfeeding? Lactation consultants can helpWhat you need to know: All the feelings during the postpartum periodPost-Partum DepressionA Better BirthQ & A: Helping Mom and BabyCheck out the Providence blog for more information on good pediatric care and all other health related topics. To learn more about our mission programs and services, go to Providence.org.Follow us on social media to get continued information on other important health care topics. You can  connect with us on LinkedIn, Facebook, TikTok, Instagram and X.For all your healthcare information on the go, download the Providence app. Whether you're tracking symptoms, scheduling appointments, or connecting with your healthcare providers, the Providence app has your back.To learn more about the app, check out the Wellness Brief podcast episode. Wellness Brief: Simplifying Care-There's an App for That.Connect with Us: Share Your Thoughts!We value your insights and would love to hear your thoughts on our recent discussions. You can reach us at FutureOfHealthPodcasts@providence.org. Let's shape the future of health together!Dr. Alex Hamling BioAlex Hamling, MD, MBA, FAAP is a board-certified pediatrician working at Pacific Medical Centers at their Bothell, WA campus.  He obtained his medical degree from Temple University School of Medicine and his MBA in Healthcare Management from the Fox School of Business at Temple University.  He completed his general pediatric residency at Cincinnati Children's Hospital Medicine Center. He is Clinical Faculty at the University of Washington's School of Medicine – Department of Family Medicine and Adjunct Faculty at Washington State University's College of Nursing.  He has been an active member as a board member in the Washington State Medical Association.  He has served on numerous committees through the American Academy of Pediatrics including teaching early career physicians through different leadership programs. During his off time, he enjoys geocaching, gardening, walking with his daughters to local coffee shops, and dancing. 

Host Jennifer Semenza welcome back Dr. Alex Hamling, pediatrician at PACMED Canyon Park-Bothell and Clinical Instructor at University of Washington School of Medicine, to continue their discussion on various aspects of children's development from ages two to six. Healthcare for young kids is consistently evolving. Tune-in to stay up to date on best practices to keep your kids happy and healthy.In this episode, Dr. Alex Hamling discusses the importance of encouraging young children to engage in physical play rather than spending time on apps. He emphasizes, laps not apps, that this practice will help children interact better with their peers and be more engaged during their early education years. He also provides information on physical and cognitive development milestones, interventions for children who may be lagging, the importance of early diagnosis for conditions like autism, and the role of a balanced diet. They also discuss common health issues such as ear infections and allergies.Dr. Alex Hamling BioAlex Hamling, MD, MBA, FAAP is a board-certified pediatrician working at Pacific Medical Centers at their Bothell, WA campus.  He obtained his medical degree from Temple University School of Medicine and his MBA in Healthcare Management from the Fox School of Business at Temple University.  He completed his general pediatric residency at Cincinnati Children's Hospital Medicine Center. He is Clinical Faculty at the University of Washington's School of Medicine – Department of Family Medicine and Adjunct Faculty at Washington State University's College of Nursing.  He has been an active member as a board member in the Washington State Medical Association.  He has served on numerous committees through the American Academy of Pediatrics including teaching early career physicians through different leadership programs. During his off time, he enjoys geocaching, gardening, walking with his daughters to local coffee shops, and dancing (salsa, swing, tango, etc.) Do you want to know more?If you would like to know more about Type 1 Diabetes please listen to the Wellness Brief: Type 1 Diabetes.Just a few of the related article from the Providence Blog:Advice From A Providence Pediatrician: Natural Remedies For KidsCough Remedies: Treating Different Types of CoughsUnderstanding RSV: Signs and SymptomsThe Stages of Child DevelopmentCheck out the Providence blog for more information on good pediatric care and all other health related topics. To learn more about our mission programs and services, go to Providence.org.Follow us on social media to get continued information on other important health care topics. You can  connect with us on LinkedIn, Facebook, TikTok, Instagram and X.For all your healthcare information on the go, download the Providence app. Whether you're tracking symptoms, scheduling appointments, or connecting with your healthcare providers, the Providence app has your back.To learn more about the app, check out the Wellness Brief podcast episode. Wellness Brief: Simplifying Care-There's an App for That.Connect with Us: Share Your Thoughts!We value your insights and would love to hear your thoughts on our recent discussions. You can reach us at FutureOfHealthPodcasts@providence.org. Let's shape the future of health together!

In this episode of Admissions Straight Talk, host Linda Abraham interviews Dr. LeeAnna Muzquiz, Associate Dean for Admissions at the University of Washington School of Medicine (UWSOM). Dr. Muzquiz, a graduate of UWSOM and a family physician with ties to the Confederated Salish and Kootenai Tribes, discusses the unique five-state WWAMI (Washington, Wyoming, Alaska, Montana, Idaho) curriculum, which allows students to complete their foundational training in their home states.The School of Medicine emphasizes training for rural and underserved communities, offering special programs like TRUST (Targeted Rural and Underserved Scholar Track) and CUSP (Community Urban Scholars Program) aimed at fostering future physicians committed to these populations. Dr. Muzquiz highlights the comprehensive and transparent admissions process at UWSOM, including the importance of personal storytelling in applications and interviews. Follow UsYouTubeFacebookLinkedInContact Uswww.accepted.comsupport@accepted.com+1 (310) 815-9553

Support the show and get 50% off MCT oil with free shipping—just leave us a review on iTunes and let us know!https://podcasts.apple.com/us/podcast/live-beyond-the-norms/id1714886566Surgery isn't just about the procedure—it's about how well you heal. And according to Dr. Cameron Chesnut, your recovery isn't just luck—it's a science.Dr. Chesnut isn't your typical plastic surgeon. The Anti-Aging Medicine World Congress called him “the best example of the new generation of modernly trained international surgeons.” And with a background spanning dermatology, facial plastics, regenerative medicine, and longevity science, he's redefining what it means to look—and feel—your best.In this episode, Dr. Chesnut breaks down why recovery is the most overlooked part of surgery, how cold plunges and hyperbaric oxygen therapy speed up healing, and why he avoids general anesthesia in favor of a cutting-edge approach that leaves his patients sharper, healthier, and pain-free.“If I have a patient who is an avid cold plunger, I know without question that they are going to handle their postoperative recovery phase leaps and bounds better than somebody who is not accustomed to that.” ~ Dr. Cameron ChesnutAbout Dr. Cameron Chesnut:Dr. Cameron Chesnut is a board-certified plastic surgeon, assistant professor at the University of Washington School of Medicine, and founder of Clinic 5C. His work integrates plastic surgery with cutting-edge regenerative medicine, helping patients not just look better—but heal and perform at their best.Resources Mentioned:- Clinic 5C: https://www.clinic5c.com/ - Unlock longevity with ESS60, the Nobel Prize-winning molecule proven to extend lifespan by 90% in lab studies. Visit MyVitalC.com to learn more.Connect with Dr. Cameron Chesnut:- Website: https://www.clinic5c.com/ - Instagram: https://www.instagram.com/chesnut.md/ - LinkedIn: https://www.linkedin.com/in/cameron-chesnut-a6910baa/ Connect with Chris Burres:- Website: https://www.myvitalc.com/ - Website: http://www.livebeyondthenorms.com/ - Instagram: https://www.instagram.com/chrisburres/ - TikTok: https://www.tiktok.com/@myvitalc - LinkedIn: https://www.linkedin.com/in/chrisburres/ 

On Tuesday the Senate Finance Committee voted to move forward with Robert F Kennedy Jr.’s nomination for Secretary of Health and Human Services. His nomination now heads to the Senate floor, where he’s expected to be confirmed. As the secretary of the HHS, Kennedy would have oversight over 11 agencies including the FDA, the CDC and the National Institutes of Health. Kennedy has come under fire from both Democrats and Republicans for some of his controversial beliefs – the most contentious being his extensive history of anti-vaccine work and rhetoric. Kennedy has in particular focused on Gardasil, the HPV vaccine. A lawyer by trade, he has helped facilitate hundreds of potential lawsuits aimed at pharmaceutical company Merck, which manufactures the drug. The vaccine is nearly 100% effective against cancers caused by the human papillomavirus – most notably cervical cancer. Kennedy has criticized the vaccine, calling it ‘dangerous and defective’ and claiming it can ‘increase the risk of cervical cancer.’ Guest: Dr. Linda Eckert, a professor in the University of Washington School of Medicine, Women's Health Division of the Department of Obstetrics and Gynecology. A leading expert in cervical cancer prevention, she's written a new book titled ENOUGH: Because We Can Stop Cervical Cancer. Relevant Links: NYT: Committee Sends R.F.K. Jr.’s Health Secretary Nomination to Full Senate Associated Press: RFK Jr. kept asking to see the science that vaccines were safe. After he saw it, he dismissed it BBC: Fact-checking RFK Jr's views on health policy Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network. See omnystudio.com/listener for privacy information.

In today's episode, supported by Amgen, we had the pleasure of speaking with Ryan Cassaday, MD, an associate professor in the Clinical Research Division at the Fred Hutchinson Cancer Center and an associate professor in the Division of Hematology and Oncology at the University of Washington School of Medicine in Seattle, Washington.  In our exclusive interview, Dr Cassaday discussed insights from several trials investigating blinatumomab (Blincyto) in patients with B-cell acute lymphoblastic leukemia (B-ALL) that were reported at the 2024 ASH Annual Meeting, including subgroup analyses of the phase 3 ECOG-ACRIN E1910 trial (NCT02003222). He also shared how findings from the phase 3 AALL1731 trial (NCT03914625) of blinatumomab plus chemotherapy in children with newly diagnosed B-ALL may be extrapolated to the adult B-ALL patient population. 

Genetic material is deeply personal, and powerful. Now, Seattle-based Variant Bio has a plan to develop drugs for metabolic disorders, using data collected from Indigenous populations. In exchange, they’re offering financial benefits and revenue sharing. We'll hear from company's Director of Ethics and Engagement and University of Washington School of Medicine bioethicist Susan Brown Trinidad. You can watch the Seattle School Board meeting here. You can watch state lawmakers talk about education funding here. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.

Dr. Anne Marie Amies Oelschlager is a Professor of Obstetrics and Gynecology and Adjunct Professor of Pediatrics at the University of Washington School of Medicine. She founded, developed, and expanded the Pediatric and Adolescent Gynecology Division at the University of Washington to provide care to patients across the Pacific Northwest, including Alaska, Idaho, Montana, and Oregon. Her clinical expertise is in contraception and hormone therapy, pubertal and menstrual disorders, congenital anomalies of reproductive organs, differences of sex development (intersex conditions), and reproductive health issues complicated by underlying physical or developmental disability or underlying medical conditions.  She also serves as Chair of the American College of Obstetricians and Gynecologists Clinical Consensus Gynecology Committee. She is a clinical instructor and lecturer on reproductive health care for the medical students at the University of Global Health Equity in Rwanda. Links mentioned: bedsider.org

Join Elevated GP: www.theelevatedgp.com https://www.kokicheducation.com/about DOT - Use the Code DENTALDIGEST for 10% off Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Connect with Melissa on Linkedin   Dr. Vince Kokich Jr. is a highly esteemed orthodontist, educator, and thought leader in the field of orthodontics and interdisciplinary dentistry. Following in the footsteps of his father, Dr. Vince Kokich Sr., a globally recognized pioneer in orthodontics, Dr. Kokich Jr. has built his own legacy by advancing innovative approaches to patient care, education, and the integration of specialties within dentistry. Educational Background Dr. Kokich Jr. earned his Doctor of Dental Surgery (DDS) degree with high honors from the University of Washington School of Dentistry, a program known for its rigorous clinical training and commitment to evidence-based care. He went on to complete his orthodontic residency at the same institution, where he honed his skills in diagnosing and treating complex malocclusions, facial growth discrepancies, and interdisciplinary cases. Throughout his education, Dr. Kokich was recognized for his academic excellence and dedication to improving patient outcomes. His passion for teaching began early in his career and has remained a cornerstone of his professional life. Professional Career Dr. Kokich Jr. has practiced orthodontics for over two decades, specializing in comprehensive treatment plans that address both functional and esthetic concerns. He is particularly renowned for his expertise in: Interdisciplinary Treatment: Collaborating with restorative dentists, periodontists, and oral surgeons to achieve optimal outcomes for complex cases. Aesthetic Orthodontics: Enhancing smiles through precision orthodontic treatment tailored to each patient's unique facial structure and goals. Education and Mentorship: Sharing his knowledge and clinical experience with the next generation of orthodontists. As an orthodontist, Dr. Kokich is committed to providing patient-centered care. His approach focuses on creating harmonious outcomes that not only align teeth but also improve facial aesthetics and long-term dental health. Educator and Speaker Dr. Kokich Jr. is a sought-after speaker at national and international dental conferences, where he shares his expertise on topics such as: Advanced interdisciplinary treatment planning. Managing complex dental esthetic cases. Incorporating emerging technologies into orthodontic practice. He has been invited to lecture for prestigious organizations and institutions, including the American Association of Orthodontists, the American Academy of Esthetic Dentistry, and various study clubs and universities worldwide. His dynamic and engaging teaching style makes him a favorite among both clinicians and students. Innovator and Founder Dr. Kokich Jr. is the creator of Kokich Education, an educational platform dedicated to elevating the knowledge and skills of dental professionals. Kokich Education offers a range of resources, from webinars and case studies to in-depth courses, empowering clinicians to tackle even the most challenging cases with confidence. The platform reflects Dr. Kokich's philosophy of interdisciplinary collaboration and lifelong learning. To learn more about Kokich Education, visit kokicheducation.com. Publications and Research Dr. Kokich Jr. has contributed to several peer-reviewed articles and textbook chapters that focus on the integration of orthodontics with other dental specialties. His work has been instrumental in advancing the understanding of how orthodontics can complement restorative and prosthetic dentistry to achieve superior outcomes. Professional Affiliations Dr. Kokich Jr. is an active member of several professional organizations, including: The American Association of Orthodontists (AAO). The American Dental Association (ADA). The Pacific Coast Society of Orthodontists (PCSO). Legacy and Vision Dr. Vince Kokich Jr. continues to honor the legacy of his father while forging his own path in orthodontics. His dedication to innovation, education, and patient care has made him a leader in the field. Through his practice, lectures, and Kokich Education, Dr. Kokich inspires clinicians worldwide to achieve excellence in their work and deliver transformative care to their patients.

Stand Up is a daily podcast that I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 700 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more GET TICKETS TO PODJAM II In Vegas March 27-30 Confirmed Guests! Professor Eric Segall, Dr Aaron Carroll, Maura Quint, Tim Wise, JL Cauvin, Ophira Eisenberg, Christian Finnegan and More! Dr. Aaron E. Carroll is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all.  Before joining AcademyHealth, Dr. Carroll was a Distinguished Professor of Pediatrics and Chief Health Officer at Indiana University, where he also served as Associate Dean for Research Mentoring and the director of the Center for Pediatric and Adolescent Comparative Effectiveness Research at Indiana University School of Medicine. He earned a B.A. in chemistry from Amherst College, an MD from the University of Pennsylvania School of Medicine, and an M.S. in health services from the University of Washington School of Public Health, where he was also a Robert Wood Johnson Clinical Scholar. Dr. Carroll's research focused on the study of information technology to improve pediatric care, decision analysis, and areas of health policy including cost-effectiveness of care and health care financing reform. He is the author of The Bad Food Bible and the co-author of three additional books on medical myths. In addition to having been a regular contributor to The New York Times and The Atlantic, he has written for many other major media outlets and is co-Editor-in-Chief at The Incidental Economist, an evidence-based health policy blog. He also has a popular YouTube channel and podcast called Healthcare Triage, where he talks about health research and health policy. Join us Thursday's at 8EST for our Weekly Happy Hour Hangout!  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing     Gift a Subscription https://www.patreon.com/PeteDominick/gift

Host Elizabeth H. Mack, MD, MS, FCCM, welcomes Elizabeth Y. Killien, MD, MPH, to discuss pediatric acute respiratory distress syndrome (PARDS). Dr. Killien explains the findings from her retrospective study on PARDS severity, emphasizing how factors such as severe hypoxemia can impact health-related quality of life (HRQL) after discharge. (Killien EY, et al. Pediatr Crit Care Med. 2024;25:816-827). Dr. Killien is an attending physician in the pediatric ICU and an assistant professor at Seattle Children's Hospital, University of Washington School of Medicine, in Seattle, Washington.

You're listening to Voices of Your Village and today I got to hang out with two pediatricians to chat about why time in nature matters for kids and how do you overcome those barriers to outdoor time. I hung out with Pooja Tandon and Danette Glassy, both doctors who work with children and have done research in this space. Dr. Tandon is a general pediatrician and researcher at the Seattle Children's Hospital, an Associate Professor at the University of Washington School of Medicine, and the Director of Health at the Trust for Public Land. She has published widely on the importance of physical activity, outdoor time, and nature contact for health. And she lives in the Seattle area with her husband and two kids. And Dr. Glassy is a Primary Care Pediatrician and Child Advocate. She's the Co -Founder and Board President of the nonprofit Best Start Washington and leads its Project Nature initiative, a program to support pediatric medical professionals as they encourage children to spend time in nature. She is the co -editor of Caring for Our Children. Dr. Glassy lives in the Seattle area and enjoys exploring nature in the Pacific Northwest with her two grandchildren. And what was so relieving about this episode is that, you know, I am not, I would not call myself one with nature. I like to be outside, like that's fun, but I'm like more outsidey than outdoorsy. And I feel like they make this so accessible, whether you're living in a city or you're living in a rural space, whether you love to hike a mountain or you want to like chill in your backyard with your kids. It just felt so much more accessible for me than a lot of the messaging around like getting outside or the 1000 hours outside or whatever can feel so overwhelming. So thank you to Dr. Tandon and Dr. Glassy for this and let's dive in.  Connect with Dr. Tandon and Dr. Glassy: Dr. Tandon LinkedIn: https://www.linkedin.com/in/pooja-s-tandon-md-mph-672040299/ Dr. Glassy LinkedIn: https://www.linkedin.com/in/danette-glassy-12b00067/ Website: https://www.projectnaturewa.com/naturebooks/ Order the book: Digging Into Nature: Outdoor Adventures for Happier and Healthier Kids Connect with us: Instagram: @seed.and.sew  Podcast page: Voices of Your Village Seed and Sew's Regulation Quiz: Take the Quiz Order Tiny Humans, Big Emotions now!  Website: seedandsew.org Music by: Ruby Adams and Bensound Learn more about your ad choices. Visit megaphone.fm/adchoices

Host Elizabeth H. Mack, MD, MS, FCCM, welcomes Elizabeth Y. Killien, MD, MPH, to discuss pediatric acute respiratory distress syndrome (PARDS). Dr. Killien explains the findings from her retrospective study on PARDS severity, emphasizing how factors such as severe hypoxemia can impact health-related quality of life (HRQL) after discharge. (Killien EY, et al. Pediatr Crit Care Med. 2024;25:816-827). Dr. Killien is an attending physician in the pediatric ICU and an assistant professor at Seattle Children's Hospital, University of Washington School of Medicine, in Seattle, Washington.

Authenticity in Medicine: A Conversation with Dr. Markus BoosIn this episode, Christine interviews Dr. Markus Boos, a pediatric dermatologist at Seattle Children's Hospital and Associate Professor at the University of Washington School of Medicine. Dr. Boos shares his personal journey of coming out at 37 and discusses the importance of authenticity in both personal and professional life. The conversation delves into the challenges of maintaining one's true self within the structured and often conformity-driven environment of medical training and practice. Dr. Boos emphasizes the value of empathy, personal connection with patients, and the need for doctors to be genuine, not just as professionals but as human beings. The discussion also touches on the impact of social expectations, personal struggles with identity, and the significance of providing a supportive and inclusive educational environment for medical residents.00:00 Introduction and Guest Welcome01:11 Personal Journey and Coming Out01:58 Reflections on Identity and Authenticity03:02 Challenges of Conformity and Self-Acceptance04:30 Balancing Professional and Personal Life07:49 Parenting and Identity10:55 The Importance of Empathy in Medicine15:42 Final Thoughts on Authenticity

In this episode: • The challenges pharmacy students face in career planning •  Redefining pharmacy career success •  Juggling work/life balance as a pharmacist •  Sharing the vulnerabilities of a pharmacist •  The importance of prioritizing mental health •  The power of networking and connection in career growth Resources Guests: Rachel G Firebaugh - Faculty at the University of Washington School of Pharmacy Brenna Molato - Clinical Assistant Professor at the University of Washington School of Pharmacy

Effective communication is essential in medicine, yet language barriers can result in suboptimal care. AI holds promise for bridging these gaps, enhancing outcomes, and reducing disparities. Casey Lion, MD, MPH, from the University of Washington School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss AI as an interpreter in the clinic. Related Content: Researcher Explores Using AI to Overcome Language Barriers With Patients Artificial Intelligence for Language Translation

This time on Code WACK! Imagine learning that your baby girl has a brain tumor that's causing seizures and disrupting her development, and your health insurance company is denying coverage for treatment her pediatric oncologist says she needs to survive and thrive? What would you do? Where did one mother turn when repeated health insurance denials delayed time-sensitive treatment to shrink her baby's tumor? To find out, we spoke to Dr. Eunice Stallman, a psychiatrist in Idaho and clinical faculty at the University of Washington School of Medicine and the University of Washington Boise Psychiatry Residency Program. Her daughter Zoey is two years old now and still undergoing medical treatment. This is the first episode in a two-part series. Check out the Transcript and Show Notes for more!

This episode includes six stories requested by listeners that wouldn't quite work as standalone episodes. The topics include: Nellie Cashman, Ela of Salisbury, Charles "Teenie" Harris, Jane Gaugain, Edward A. Carter Jr., and Alice Ball. Research: ·       National Parks Service. “Nellie Cashman.” https://www.nps.gov/articles/000/nellie-cashman.htm Arizona Women's Hall of Fame. “Nellie Cashman.” https://www.azwhf.org/copy-of-pauline-bates-brown-2 ·       Backhouse, Frances. “Angel of the Cassiar.” British Columbia Magazine. Winter 2014. ·       Hawley, Charles C. and Thomas K. Bundtzen. “Ellen (Nellie) Cashman.” Alaska Mining Hall of Fame Foundation. https://alaskamininghalloffame.org/inductees/cashman.php ·       Clum, John P. “Nellie Cashman.” Arizona Historical Review. Vol. 3, No. 4. January 1931. ·       Porsild, Charlene. “Cashman, Ellen.” Dictionary of National Biography. Vol. XV (1921-1930). https://www.biographi.ca/en/bio/cashman_ellen_15E.html ·       Ward, Jennifer C. "Ela, suo jure countess of Salisbury (b. in or after 1190, d. 1261), magnate and abbess." Oxford Dictionary of National Biography. October 08, 2009. Oxford University Press. Date of access 30 Oct. 2024, https://www.oxforddnb.com/view/10.1093/ref:odnb/9780198614128.001.0001/odnb-9780198614128-e-47205 ·       McConnell, Ally. “The life of Ela, Countess of Salisbury.” Wiltshire & Swindon History Centre. https://wshc.org.uk/the-life-of-ela-countess-of-salisbury/ Order fo Medieval Women. “Ela, Countess of Sudbury.” https://www.medievalwomen.org/ela-countess-of-salisbury.html. Charles “Teenie” Harris Archive. Carnegie Museum of Art. https://carnegieart.org/art/charles-teenie-harris-archive/ ·       National Museum of African American History and Culture. “Photojournalist, Charles “Teenie” Harris.” https://nmaahc.si.edu/photojournalist-charles-teenie-harris ·       O'Driscoll, Bill. “Historical marker honors famed Pittsburgh photographer Teenie Harris.” WESA. 9/30/2024. https://www.wesa.fm/arts-sports-culture/2024-09-30/historical-charles-teenie-harris-pittsburgh-photography ·       Kinzer, Stephen. “Black Life, In Black And White; Court Ruling Frees the Legacy Of a Tireless News Photographer.” New York Times. 2/7/2001. https://www.nytimes.com/2001/02/07/arts/black-life-black-white-court-ruling-frees-legacy-tireless-photographer.html ·       Hulse, Lynn. "Gaugain [née Alison], Jane [Jean] (1804–1860), author, knitter, and fancy needleworker." Oxford Dictionary of National Biography. August 08, 2024. Oxford University Press. Date of access 30 Oct. 2024, https://www.oxforddnb.com/view/10.1093/odnb/9780198614128.001.0001/odnb-9780198614128-e-90000382575 ·       "Edward A. Carter, Jr." Contemporary Black Biography, vol. 104, Gale, 2013. Gale In Context: U.S. History, link.gale.com/apps/doc/K1606005739/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=77e0beae. Accessed 30 Oct. 2024. ·       National WWII Museum. “Staff Sergeant Edward A. Carter Jr's Medal of Honor.” 2/15/2021. https://www.nationalww2museum.org/war/articles/staff-sergeant-edward-carter-jr-medal-of-honor ·       Lange, Katie. “Medal of Honor Monday: Army Sgt. 1st Class Edward Carter Jr.” U.S. Department of Defense. https://www.defense.gov/News/Feature-Stories/Story/Article/3347931/medal-of-honor-monday-army-sgt-1st-class-edward-carter-jr/ ·       National Parks Service. “Edward Carter Jr.” Charles Young Buffalo Soldiers National Monument. https://www.nps.gov/people/edwardcarterjr.htm ·       Dwyer, Mitchell K. “A Woman Who Changed the World.” University of Hawaii Foundation. https://www.uhfoundation.org/impact/students/woman-who-changed-world ·       University of Washington School of Pharmacy. “UWSOP alumni legend Alice Ball, Class of 1914, solved leprosy therapy riddle.” https://sop.washington.edu/uwsop-alumni-legend-alice-ball-class-of-1914-solved-leprosy-riddle/ ·       Ricks, Delthia. “Overlooked No More: Alice Ball, Chemist Who Created a Treatment for Leprosy.” 5/8/2023. https://www.nytimes.com/2023/04/08/obituaries/alice-ball-overlooked.html  See omnystudio.com/listener for privacy information.

This time on Code WACK! Imagine learning that your baby girl has a brain tumor that's causing seizures and disrupting her development, and your health insurance company is denying coverage for the treatment her pediatric oncologist says she needs to survive and thrive? What would you do? Where did one mother turn when repeated health insurance denials delayed time-sensitive treatment to shrink her baby's tumor?  To find out, we spoke to Dr. Eunice Stallman, a psychiatrist in Idaho and clinical faculty at the University of Washington School of Medicine and the University of Washington Boise Psychiatry Residency Program. Her daughter Zoey is two years old now and still undergoing medical treatment. This is the first episode in a two-part series. Check out the Transcript and Show Notes for more!  

Calcific aortic stenosis affects approximately 12% of people >75 years in the US and worldwide leads to more than 100 000 deaths each year. Catherine M. Otto, MD, PhD, of the University of Washington School of Medicine, Seattle, discusses the symptoms, diagnosis, and treatment of aortic stenosis with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content: Calcific Aortic Stenosis

AI itself isn't a goal. In the enterprise, marketers that effectively integrate artificial intelligence into their operations in meaningful ways will start to see the tangible returns that leaders in the space are already realizing. Today we're going to talk about the reality of AI adoption in the enterprise, and how marketers should be thinking about a workplace where humans and AI agents are working together. To help me discuss this topic, I'd like to welcome Adam Brotman, Co-Founder and Co-CEO, Forum3. Adam Brotman is co-founder and co-CEO of Forum3. Previously, he was president, chief experience officer, and co-CEO at J.Crew, where he launched the widely successful J.Crew Rewards program. At Starbucks, he was the inaugural chief digital officer and evp, global retail operations, developing the payment, ordering, and loyalty platform which amassed 60 million members. He has been recognized as one of Fast Company's 100 Most Creative People and CDO Club's CDO of the Year. He serves on the boards of Ruby Tuesday and Cabi, and has held board positions at Neiman Marcus Group and Brooks Running. He is the co-author of AI First, in collaboration with Harvard Business Review, and received his bachelor's degree from UCLA and JD from The University of Washington School of Law. RESOURCES Forum3 website: https://www.forum3.com/ Spok website: https://www.spok.app/ Wix Studio is the ultimate web platform for creative, fast-paced teams at agencies and enterprises—with smart design tools, flexible dev capabilities, full-stack business solutions, multi-site management, advanced AI and fully managed infrastructure. https://www.wix.com/studio Attend the Mid-Atlantic MarCom Summit, the region's largest marketing communications conference. Register with the code "Agile" and get 15% off. Register now for HumanX 2025. This AI-focused event which brings some of the most forward-thinking minds in technology together. Register now with the code "HX25p_tab" for $250 off the regular price. Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstrom Don't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.show Check out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnow The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company

Are you looking for ways to foster happier and healthier habits in your teens? Have you ever wondered how spending time outdoors could benefit both your teens and your relationship with them? In this episode of the Power Your Parenting: Moms with Teens podcast, Colleen O'Grady discusses the powerful role that nature plays in the development and mental well-being of tweens, teens, and young adults. Joined by experts Dr. Pooja Sarin Tandon and Dr. Danette Swanson Glassie, the conversation dives into how nature can improve executive functioning, cognitive skills, and resilience in teens. The guests emphasize that exposure to nature helps develop life skills, such as planning, decision-making, and building strong social connections, all while reducing stress and anxiety. They also highlight that nature doesn't have to mean grand adventures; even small, nearby nature experiences, like walking in a park or stargazing, can have a big impact. POOJA SARIN TANDON, MD, MPH, FAAP, is a general pediatrician and researcher at the Seattle Children's Hospital, an associate professor at the University of Washington School of Medicine, and the director of health at the Trust for Public Land. She has published widely on the importance of physical activity, outdoor time, and nature contact for health. She lives in the Seattle area with her husband and two children.   DANETTE SWANSON GLASSY, MD, FAAP, is a primary care pediatrician and child advocate. She is the cofounder and board president of the nonprofit BestStart Washington and leads its Project Nature initiative—a program to support pediatric medical professionals as they encourage children to spend time in nature. She is the coeditor of Caring for Our Children. Dr. Glassy lives in the Seattle area and enjoys exploring nature in the Pacific Northwest with her two grandchildren. Key takeaways from the episode include the idea that nature provides a unique opportunity for teens to practice independence and resilience, as well as giving families a chance to bond in a stress-free environment. Parents are encouraged to integrate nature into everyday life, whether through shared outdoor activities or giving teens the space to explore on their own. Finally, the episode offers a gentle reminder that nature isn't just for kids; it's a powerful parenting tool for moms to reduce their own stress and build better connections with their teens. To find out more about their new book Digging into Nature go to https://www.projectnaturewa.com/naturebooks/ Dr. Tandon: https://www.linkedin.com/in/pooja-s-tandon-md-mph-672040299/   Dr. Glassy: https://www.linkedin.com/in/danette-glassy-12b00067/   Learn more about your ad choices. Visit megaphone.fm/adchoices